Quick Answer
AbbVie Inc. reported Cash And Cash Equivalents At Carrying Value of $5.23 billion for the year ending 2025.
- AbbVie Inc. showed a decrease of -5.3% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from AbbVie Inc.'s annual report (Form 10-K), filed with the SEC on February 20, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2012: $41.00 million | Q2 2012: $74.00 million | Q3 2012: $2.76 billion | Q1 2013: $6.98 billion | Q2 2013: $8.74 billion | Q3 2013: $8.98 billion | Q1 2014: $8.14 billion | Q2 2014: $9.09 billion | Q3 2014: $7.72 billion | Q1 2015: $7.91 billion | Q2 2015: $7.40 billion | Q3 2015: $9.22 billion | Q1 2016: $7.56 billion | Q2 2016: $6.33 billion | Q3 2016: $6.22 billion | Q1 2017: $4.74 billion | Q2 2017: $6.09 billion | Q3 2017: $8.45 billion | Q1 2018: $9.01 billion | Q2 2018: $3.55 billion | Q3 2018: $8.02 billion | Q1 2019: $4.90 billion | Q2 2019: $5.17 billion | Q3 2019: $10.65 billion | Q1 2020: $41.14 billion | Q2 2020: $6.02 billion | Q3 2020: $7.89 billion | Q1 2021: $9.76 billion | Q2 2021: $8.55 billion | Q3 2021: $12.18 billion | Q1 2022: $6.10 billion | Q2 2022: $8.52 billion | Q3 2022: $11.83 billion | Q1 2023: $6.71 billion | Q2 2023: $8.76 billion | Q3 2023: $13.29 billion | Q1 2024: $18.07 billion | Q2 2024: $13.13 billion | Q3 2024: $7.26 billion | Q1 2025: $5.18 billion | Q2 2025: $6.47 billion | Q3 2025: $5.63 billion.
- Over the full 16 years of available data (2010 to 2025), AbbVie Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 52,190.0%.
- Historical annual values: Fiscal year 2025: $5.23 billion | Fiscal year 2024: $5.52 billion | Fiscal year 2023: $12.81 billion | Fiscal year 2022: $9.20 billion | Fiscal year 2021: $9.75 billion | Fiscal year 2020: $8.45 billion | Fiscal year 2019: $39.92 billion | Fiscal year 2018: $7.29 billion | Fiscal year 2017: $9.30 billion | Fiscal year 2016: $5.10 billion | Fiscal year 2015: $8.40 billion | Fiscal year 2014: $8.35 billion | Fiscal year 2013: $9.60 billion | Fiscal year 2012: $5.90 billion | Fiscal year 2011: $27.00 million | Fiscal year 2010: $10.00 million.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: